Daniel Barber is President and Chief Executive Officer of Aquestive Therapeutics, Inc. (AQST). The company reported total compensation of $3,493,559 for fiscal year 2025.
| Salary | $659,885 |
|---|---|
| Bonus | $0 |
| Stock awards | $1,547,342 |
| Option awards | $877,200 |
| Non-equity incentive plan | $409,132 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $0 |
| Total | $3,493,559 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Aquestive Therapeutics, Inc. filed April 24, 2026, accession 0001140361-26-016757.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Daniel Barber this page | President and Chief Executive Officer | $3,493,559 |
| Lori Braender | Corporate Secretary, Former Chief Legal Officer and Chief Compliance Officer | $1,348,238 |
| A. Ernest Toth, Jr. | Chief Financial Officer | $1,323,547 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Aquestive Therapeutics, Inc. compensation brief.
Daniel Barber's compensation sits inside Aquestive Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.